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Abstract  28 
Background: Diabetes prevention programmes delay or prevent the onset of type 2 29 
diabetes in people with pre-diabetes. To increase accessibility, national guidelines 30 
recommend delivering diabetes prevention programmes in primary care settings, including 31 
community pharmacy. This study aimed to explore the English community pharmacy setting 32 
as an option for delivering diabetes prevention services. 33 
  34 
Methods: Two focus groups and nine semi-structured interviews were conducted with 35 
stakeholders including, community pharmacists, general practitioners and commissioners. 36 
The topic guide was framed using the COM-B theoretical model for behaviour change to 37 
elicit practitioners’ capability, opportunity and motivation to engage with providing or referring 38 
to community pharmacy diabetes prevention services. Data were analysed thematically, and 39 
barriers/facilitators mapped to the COM-B framework.  40 
 41 
Results: Five themes were identified: ‘Pre-diabetes management and associated 42 
challenges’, ‘The community pharmacy setting’, ‘Awareness of community pharmacy 43 
services’, ‘Relationships and communication’ and ‘Delivery of community pharmacy 44 
services’. Community pharmacy was highlighted as an accessible setting for delivering 45 
screening and follow-on lifestyle interventions. Key factors for enhancing the capability of 46 
community pharmacy teams to deliver the interventions included training and appropriate 47 
use of skill mix. Delivering diabetes prevention services in collaboration with general 48 
practices was identified as key to the provision of integrated primary care services.  Whilst 49 
financial incentives were identified as a motivating factor for delivery, service promotion to 50 
patients, public and healthcare professionals was perceived as crucial for enhancing 51 
engagement.  52 
 53 
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Conclusions: This research highlights a role for community pharmacy in diabetes 54 
prevention. New service models should seek to integrate community pharmacy services in 55 
primary care to facilitate patient engagement and better communication with general 56 
practices. 57 
 58 
 59 
 60 
Introduction 61 
In England, approximately five million people have pre-diabetes (1). It is estimated that 5-10% 62 
of people with pre-diabetes develop type 2 diabetes every year, although this may vary with 63 
population characteristics and pre-diabetes definitions (2, 3). Evidence indicate that early 64 
identification of individuals with pre-diabetes and subsequent implementation of behaviour 65 
change related to diet and physical activity can significantly reduce progression to type 2 66 
diabetes (4). However, systematic review evidence suggests that the impact of diabetes 67 
prevention programmes (DPPs) could be undermined by poor engagement amongst people 68 
with pre-diabetes (5).  69 
 70 
A National Health Service DPP (NHS DPP) in England, which aims to identify people with pre-71 
diabetes and refer them onto a behavioural change group-based intervention, was 72 
implemented in 2016 (6). A recent update on the programme reported a post-referral 73 
attendance rate of 49% to the initial assessment (7). Qualitative evidence exploring 74 
engagement with DPPs has identified possible barriers to include work and social 75 
commitments, inconvenient location and session times and transportation (8-10).  76 
 77 
Primary care settings demonstrate the greatest reach to people with pre-diabetes (11). In 78 
England, community pharmacy is the most visited NHS primary care setting, with 79 
approximately 90% of the population having access within a 20 minute walk (12). Evidence 80 
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investigating the implementation of DPPs in community pharmacy settings has demonstrated 81 
feasibility in the delivery of both screening and lifestyle-change interventions (13, 14). In 82 
countries such as the USA, where a national DPP has been implemented for a number of 83 
years, clear guidelines outlining community pharmacy involvement in pre-diabetes screening 84 
and delivery of DPPs have been developed (15).  85 
 86 
In England however, with pre-diabetes primarily identified through routine primary care 87 
appointments or retrospective screening of general practice databases, the role of community 88 
pharmacy in the delivery of the program remains undefined (16, 17). Additionally, although 89 
community pharmacy delivers opportunistic screening and refers to mainly general practice 90 
services (18), there are currently no routine lifestyle interventions being delivered in this setting 91 
for people with pre-diabetes. Nor are there clear guidelines for how community pharmacists 92 
could deliver lifestyle interventions for this population. Therefore, with the NHS long term plan 93 
advocating involvement of community pharmacists in primary care networks for case finding 94 
and treating high risk conditions (19), it is important to establish a clear role for community 95 
pharmacy in the national programme and determine whether it could increase reach to this 96 
population. Additionally, there is a need to better understand the likely barriers and facilitators 97 
to delivering public health interventions in this setting from the perspective of multiple 98 
stakeholders including community pharmacy teams, general practice teams and 99 
commissioners. 100 
 101 
Successful delivery of public health interventions such as DPPs in this community pharmacy 102 
would require behaviour change at many levels including individual (pharmacists), 103 
organisational (community pharmacy) and community (primary care and local communities) 104 
(20). In this study we applied the COM-B, a theoretical model which recognises that behaviour 105 
change is brought about by interacting components including Capability, Opportunity and 106 
Motivation, to understand the key determinants for ‘the delivery of diabetes prevention 107 
services (DPS) by community pharmacy teams’ (21).  The aim of this research was therefore 108 
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to explore the community pharmacy setting as an option for delivering DPS by eliciting views 109 
of stakeholders and using the COM-B model to frame the data collection, analysis and future 110 
direction of interventions aimed at patients and healthcare professionals. 111 
 112 
Methods 113 
Study design  114 
This is a qualitative study that adopted a pragmatic epistemology and used semi-structured 115 
interviews and focus groups to explore the study aims with various stakeholder groups (22). 116 
Ethical approval was obtained from the Health Research Authority (IRAS project ID: 233631) 117 
and the Faculty of Medicine and Health Sciences Research Ethics committee at the 118 
University of East Anglia before commencing the research. The study took place in Norfolk, 119 
UK between January and March 2018. 120 
 121 
Rationale for study design 122 
A pragmatic and exploratory approach was used to address this research topic in which very 123 
little research has previously been undertaken (22, 23). Pragmatism, a philosophy that 124 
recognizes that there are different ways of interpreting the world and research, suggests 125 
there to be multiple realities and hence that no single point of view can ever give the entire 126 
picture (24, 25). Pragmatic research therefore seeks to use whatever combination of 127 
methods necessary to find the answers to research questions. This study adopted the use of 128 
both focus groups and interviews to explore the research topic with multiple stakeholders. 129 
Focus groups were deemed central to exploring the research topic in the selected group of 130 
participants who often work as a team to deliver services (26). However, in order to provide 131 
flexibility to potential participants and thus encourage participation, the interview option was 132 
made available to GPs, nurses and commissioners. This option was also used to support an 133 
honest in-depth account of experiences and opinions about community pharmacy and 134 
community pharmacy teams from this group of participants. 135 
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Study setting 136 
This study was set in primary care, specifically community pharmacy and general practice 137 
settings(27). General practices are private healthcare businesses that have an important role 138 
in providing healthcare to local communities. In the UK, although the majority of general 139 
practices work to NHS contracts, follow NHS guidelines and see NHS patients, they do not 140 
compete for patients, or profit in the way privately funded providers of healthcare do. 141 
General practices consist of multidisciplinary teams including general practitioners (doctors), 142 
nurses and pharmacists and are responsible for both looking after patients with chronic 143 
illness and health promotion. Community pharmacies are also private healthcare providers 144 
who work to NHS contracts to provide medicine related services such as dispensing and 145 
counselling. As part of their contract community pharmacies also provide health promotion 146 
services such as weight loss and smoking cessation programmes.  147 
 148 
In England, local health promotional services provided by both general practices and 149 
community pharmacies are commissioned by Clinical Commissioning Groups (CCGs)(28). 150 
Clinical commissioning groups are groups of general practices which come together in an 151 
area to commission the most appropriate services for their patients and population. These 152 
groups therefore buy services for their local community from any service provider, including 153 
community pharmacy, which meet NHS standards and costs. Commissioners are usually 154 
supported by Clinical Support Units with external support, specialist skills and knowledge 155 
and may also consult Local Pharmaceutical Committees (LPCs), who represent all 156 
pharmacy contractors in a defined area, on services that could potentially be provided via 157 
community pharmacy. 158 
This study involved multiple stakeholders involved in both the provision and commissioning 159 
of local health promotional and preventative services in order to obtain a more complete 160 
perspective on a potential role of community pharmacy in delivering DPPs in primary care.  161 
 162 
 163 
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Participants  164 
Eligible participants were community pharmacy personnel, general practitioners and nurses 165 
working in the UK. Community pharmacy personnel included pharmacists and technicians 166 
involved in the delivery of public health services. General practitioners, nurses and other 167 
pharmacists were only eligible if they were working for general practices participating in pre-168 
diabetes screening and referral to the NHS DPP and had a special interest in diabetes. 169 
Individuals involved in commissioning and negotiating services for community pharmacy 170 
were also eligible to participate in the study.  171 
 172 
Participant identification and approach  173 
Research information was circulated to potential participants in community pharmacies and 174 
general practices via emails sent through area, store and practice managers. 175 
Commissioners were identified and sent research information through the Research and 176 
Development office and/or existing contacts.  177 
 178 
Participants involved in focus groups and interviews conducted outside of working hours 179 
were reimbursed for travel costs and received a £30 voucher for participating. General 180 
practices were reimbursed at £80 per hour for GP time and £23.21 per hour for nurses’ time 181 
for interviews conducted during working hours. Participating commissioners declined the 182 
offer of a voucher at £30 per hour, instead choosing to participate for free. 183 
 184 
Sampling 185 
The study aimed to conduct two focus groups and a maximum of 10 interviews. To ensure a 186 
good representation from chain and independent pharmacies recruiting of community 187 
pharmacy participants involved purposive sampling based on job titles and workplace (26). 188 
We aimed to achieve a focus group size ranging from 5 to 8 participants (26). Convenience 189 
sampling was used to recruit commissioners, GPs and nurses. All GPs, nurses and 190 
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commissioners opted for interviews rather than focus groups, hence focus groups were only 191 
conducted with community pharmacy participants.  192 
 193 
Data collection  194 
Semi-structured interviews were conducted at the University of East Anglia or participants’ 195 
workplace by the main researcher (TK) and lasted up to a maximum of 30 minutes. Focus 196 
groups were held at the University of East Anglia and facilitated by the main researcher (TK) 197 
and another member of the research team and lasted approximately 60 minutes. Both 198 
interviews and focus groups were digitally audio recorded. Written consent was obtained 199 
from all participants.  200 
 201 
Topic guide 202 
The semi structured topic guide used to facilitate data collection for both interviews and 203 
focus groups is summarised in Table 1. It was developed based on a review of literature, 204 
discussion among the research team and underpinned by the COM-B theoretical model (21). 205 
The topic guide was tailored to the appropriate healthcare professional group or 206 
commissioner, but the key issues remained the same. 207 
 208 
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Table 1: Topic guide summary 209 
  210 
Research topic Issues discussed  
Background   Current job role and work experience  
 
Pre-diabetes (where 
applicable) 
 Experience with the management of pre-diabetes  
 
Community pharmacy 
services  
 Experience and views about current community pharmacy services  
 Views on current primary care based public health services e.g. NHS Health Checks  
 
Community pharmacy-
based diabetes prevention  
 Views on the role of community pharmacy in diabetes prevention  
 Capability: barriers and facilitators for using community pharmacy personnel to deliver diabetes prevention 
services  
 Opportunity: barriers and facilitators for using the community pharmacy setting for delivering of diabetes 
prevention services 
 Motivation: barriers and facilitators for community pharmacy teams delivering diabetes prevention services 
as part of the primary care team 
 211 
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Analysis  212 
Interviews and focus group recordings were transcribed verbatim by the main researcher 213 
(TK) or a paid contractor. To provide an iterative process of analysis Braun and Clarke’s six 214 
phases of thematic analysis were conducted (29). The transcribed data were re-read and 215 
inductively coded by the main researcher (TK). Relationships between the codes were 216 
sought to develop subthemes and subsequent themes by two members of the research 217 
team (TK and HA). Codes and themes were checked by another member of the research 218 
team (MT) and any disagreements resolved by consensus, referring to the transcripts.  219 
 220 
To facilitate a theory informed analysis, themes associated with the target behaviour (i.e. the 221 
community pharmacy team delivering DPS) were identified by two members of the research 222 
team (TK and MT). Respective codes from the themes were then separated into barriers and 223 
facilitators and mapped onto the three domains of the COM-B model i.e. capability, 224 
opportunity and motivation. Mapping was carried out independently by three researchers 225 
(TK, HA and MT). Following this, the mapping was further checked by another member of 226 
the research team (HF) with a psychology background and experience in using the COM-B. 227 
Any disagreements were resolved by consensus, referring to the codes and original 228 
transcripts. 229 
 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
 238 
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Results 239 
Two focus groups (N=7 and N=5) with community pharmacy participants and 9 interviews 240 
with GPs, nurses and commissioners were conducted. Participant characteristics are 241 
summarised in Table 2. Thematic analysis identified the following five main themes: ‘Pre-242 
diabetes management and associated challenges’, ‘The community pharmacy setting’, 243 
‘Awareness of community pharmacy services’, ‘Relationships and communication’ and 244 
‘Delivery of community pharmacy services’. The first theme sets the context for the current 245 
management of people with pre-diabetes in primary care which is largely carried out in 246 
general practice whilst subsequent themes relay factors associated with delivering DPS in 247 
community pharmacy.  What follows aims to provide a narrative on the first theme to provide 248 
context, followed by the COM-B analysis of the subsequent themes.  249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
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Table 2: Participant characteristics 266 
Characteristic  Total (N=21) 
N (%) 
Gender   
 Female  16 (76.2) 
 
Profession  
 
 Pharmacist (registered) 8 (38.1) 
 Pharmacist (pre-registration) 1 (4.8) 
 Pharmacy technician  3 (14.3) 
 General practitioner  3 (14.3) 
 General practice pharmacist 1 (4.8) 
 Nurse  3 (14.3) 
 Commissioner (pharmacist)   1 (4.8) 
 Commissioner (non-healthcare professional) 1 (4.8) 
 
Place of work  
 
 Pharmacy chain 9 (42.9) 
 Independent pharmacy  3 (14.3) 
 General practice  7 (33.3) 
 Commissioner (Local Pharmaceutical Committee-non-
healthcare professional)   
1 (4.8) 
 Commissioner (Commissioning Support Unit - pharmacist) 1 (4.8) 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
 274 
 275 
 276 
 277 
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Theme 1: Pre-diabetes management and associated challenges 278 
General practice participants largely welcomed the NHS DPP as a referral option that saved 279 
them time and allowed them to focus on other conditions. These participants reported 280 
positive feedback from patients who had engaged with the programme with respect to weight 281 
loss and lowering HbA1c. However, despite the implementation of the NHS DPP, there was 282 
a variation in its utilisation by participants working in general practices who described using 283 
different pre-diabetes management protocols. GP and nurse participants described providing 284 
diet and lifestyle advice using, but not limited to, leaflets and face to face or telephone 285 
consultations.  286 
 “It is a good option [NHS DPP] I do feel because of the time element and obviously we’re 287 
really busy in primary care. Whilst I would always offer that time to the patient equally if they 288 
say, ‘yes I will go on the diabetes prevention’, that does then reduce that, not burden, but it 289 
transfers that responsibility over” [P18-Nurse] 290 
 291 
Experience with referral to the NHS DPP was also varied amongst GP and nurse 292 
participants. Whilst most GP participants felt that people with pre-diabetes were generally 293 
receptive to their referral to the NHS DPP, most nurse participants felt that uptake was low 294 
and largely affected by location and transportation. Apart from accessibility, other barriers to 295 
participation included social and work commitments, a dislike of group-based sessions and 296 
patients’ perceptions that they had adequate knowledge and capability to make changes 297 
themselves. Some nurse participants also felt that engagement was noticeably low amongst 298 
people with co-morbidities and those from low socioeconomic backgrounds. 299 
 300 
“The other thing is a lot don’t like groups…the minute I found that I say oh you know it’s a 301 
group session, they say, ‘oh no I don’t want to go, I don’t do groups’ ” [P16-Nurse] 302 
 303 
 304 
 305 
 306 
14 
 
COM-B analysis 307 
Four themes, briefly described below, were directly related to the target behaviour 308 
‘community pharmacy teams delivering DPS’ and thus included in the COM-B analysis. The 309 
separation of the codes in each theme into barriers and facilitators, illustrative quotes and 310 
mapping onto the Capability, Opportunity and Motivation domains is presented in Table 3 311 
(see end of manuscript due to length) together with the descriptions of the domains. 312 
 313 
Theme 2: The community pharmacy setting 314 
This theme largely discussed physical characteristics of the setting such as accessibility in 315 
relation to engagement of people with pre-diabetes with DPS. Barriers and facilitators related 316 
to delivering DPS in community pharmacy included time and resources and as such were 317 
mapped to the physical opportunity domain.    318 
 319 
Theme 3: Awareness of community pharmacy services 320 
This theme considered the societal role of community pharmacy in public health and primary 321 
care. The theme, largely discussing the level of awareness of community pharmacy services 322 
by the public, patients and other healthcare professionals, identified barriers and facilitators 323 
which were primarily mapped to the social opportunity domain.  324 
 325 
Theme 4: Relationships and communication  326 
This theme discussed communication challenges between community pharmacies and 327 
general practices and the impact of relationships in enhancing and hindering communication 328 
and delivery of services. Barriers and facilitators relating to this theme were mapped onto the 329 
opportunity and motivation domains.   330 
 331 
Theme 5: Delivery of community pharmacy services 332 
This theme explored the practical aspects of delivering public health services, including 333 
DPS, in community pharmacy. The theme considered the capability of community pharmacy 334 
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teams, the availability of physical resources and the motivation behind wanting to engage 335 
with delivering the services. Hence the theme contributed to all three domains.  336 
 337 
 338 
Capability 339 
Training was identified as the main enabler for enhancing capability of community pharmacy 340 
teams to deliver DPS. Whilst most participants perceived pharmacists to have adequate 341 
knowledge to deliver DPS, they felt other team members, such as technicians and 342 
dispensers who work under supervision of pharmacists, would need a sound theoretical 343 
understanding of pre-diabetes and its management. Participants felt that this was crucial for 344 
giving other team members autonomy, subsequently requiring less pharmacist intervention. 345 
Practical training was also perceived to be crucial for all members of the team including 346 
pharmacists. 347 
“I think if the CCG is commissioning a service then they should be able to provide us with the practical 348 
training” [P4-Pharmacist] 349 
Other training requirements highlighted as important for supporting people with pre-diabetes 350 
in the making desired lifestyle changes included coaching, behaviour change and 351 
consultation skills. In general, most participants felt that, with training, any personnel 352 
including community pharmacy teams could deliver DPS. 353 
“I’m sure we’ve had consultations whether it be with a healthcare assistant or a nurse or a doctor 354 
where we think, ‘that could have been a little bit better’, and so I would want to ensure that when 355 
people are coming into our pharmacy that they’re having a positive experience with the member of 356 
staff who is delivering the services to them” [P8-Pharmacist] 357 
 358 
Physical opportunity  359 
Community pharmacy was perceived as well-placed for delivering pre-diabetes screening 360 
services that could afford a faster referral pathway into the NHS DPP. Accessibility was 361 
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considered as an enabler for engagement of people with pre-diabetes, with key setting 362 
characteristics including location and the provision of walk-in services.  363 
“Well for a start we are more accessible. We open seven days a week…it’s not like Monday to Friday 364 
the GP’s…they [patients] can come in over the weekend and see someone as well. It might be a good 365 
thing [to deliver DPS]” [P5-Pharmacist] 366 
 367 
In considering the practical delivery of DPS, community pharmacy participants identified time 368 
as a key facilitator. Participants felt that delivering public health interventions requires 369 
adequate time and resources, which when compromised, often lead to low quality, “tick box” 370 
services. The lack of access to full patient medical records and IT systems which are not 371 
merged were considered as barriers to efficient communication and referrals between 372 
community pharmacy and general practice. 373 
“You need the IT solutions etc. to be able to pass that information back to the GP practice because at 374 
the moment it’s not an integrated system. So IT connectivity and read write abilities etc. are kind of 375 
fundamental I think to the integration of community pharmacy service going forward”  376 
[P20-Commissioner] 377 
A major concern highlighted by community pharmacy participants and commissioners was 378 
the current funding cuts and the lack of dedicated budgets for services commissioned in this 379 
setting. It was therefore felt that reasonable reimbursement would be required to account for 380 
the time and resources invested in delivering future services. 381 
“The problem is the chicken and egg. Does pharmacy develop and staff itself for those services, but 382 
how does it do so before the funding and everything becomes available?” [P20-Commissioner] 383 
 384 
Social opportunity  385 
Community pharmacy was considered to have potential for increasing patient centred care 386 
by providing more choice. Participants felt community pharmacy could increase reach to 387 
men and regular pharmacy users due to the settings’ propensity for normalising care and the 388 
non-judgemental and anonymous environment it provides. It was also seen as suitable for 389 
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accommodating an individualised intervention as an alternative to the current group 390 
intervention offered in the national DPP. 391 
“I think another benefit [of community pharmacy-based DPS] is also that they develop that link with 392 
their pharmacist. I guess perhaps that would be it, that if you’ve got somebody that’s on quite a few 393 
medications anyway they’re used to going to the pharmacist, it’s not a big deal”  [P19- GP practice 394 
pharmacist] 395 
Although community pharmacy participants considered the delivery of DPS to be part of their 396 
public health role, they felt there is a general lack of awareness of this role amongst patients, 397 
the public and other primary care teams. This resonated amongst general practice 398 
participants who, although aware of medicine-related services, seemed unaware of the 399 
range of public health interventions delivered in community pharmacies. Additionally, 400 
commissioners and some community pharmacy participants expressed concerns that NHS 401 
promotional campaigns had so far presented community pharmacy as a cheaper alternative 402 
to general practice. These participants were referring to ‘Stay Well Pharmacy Campaign’ 403 
launched in 2018 to encourage the public to visit their local pharmacy team first for clinical 404 
advice for minor health concerns (30).  This campaign was launched in a climate in which 405 
millions of GP appointments and visits to emergency services were for treatable conditions 406 
and estimated to cost the NHS more than £850m each year (31). Therefore, although the 407 
key message of the campaign was that community pharmacists and technicians are qualified 408 
healthcare professionals and well suited to meet the clinical need, these participants 409 
perceived the underlying message of the campaign, which is that using pharmacy for minor 410 
concerns will free up GP time for more urgent appointments and save NHS money, to be 411 
more prominent. These participants conveyed the need for promotion centred on accessing 412 
the right level of care. 413 
“If you change the message to, ‘you’re still going to get primary care services you’re just accessing it 414 
at a more appropriate place’, it’s a different message and it might drive behaviours to change because 415 
as a patient if you get told you are going to see the cheap alternative you might not want to go there” 416 
[P21-Commissioner]. 417 
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The delivery of DPS such as screening and lifestyle programmes as part of the primary care 418 
team was also discussed. Community pharmacy participants felt that service endorsement 419 
by GPs and nurses involved in the diagnoses pre-diabetes was crucial to service uptake. 420 
However, some participants felt that endorsement of, and referral to, community pharmacy 421 
services by general practices was largely dependent on working relationships. 422 
 423 
Some participants felt that the delivery of DPS in community pharmacy could generate 424 
resistance from both GPs and patients. To this end some participants described how 425 
screening services which mainly refer to general practice for confirmatory tests, could create 426 
extra workload and negatively affect their revenue. One GP in particular felt disadvantaged 427 
by current screening services which refer patients at high risk of cardiovascular diseases or 428 
diabetes to them as they felt that community pharmacy was getting paid to do the easy part 429 
whilst general practices were left to deal with the long-term management of the conditions 430 
for no extra payment. For this reason, the participant expressed a need for pharmacists to 431 
be empowered to do thorough screening tests requiring no referral for confirmatory tests and 432 
that community pharmacy teams should also be empowered to either refer straight into the 433 
NHS DPP or provide follow-on preventative services. Although this view was not expressed 434 
by all, community pharmacy participants also acknowledged the lack of follow-on services in 435 
this setting.  436 
“If GPs are to trust that what they [community pharmacy teams] are doing, they are doing it properly 437 
and then the GPs don’t have to take up the extra burden but not be paid for it, then I think it would 438 
work well…with regards to services moving out of primary care, I mean, if GPs provide the screening 439 
services we get kind of paid for it and it’s a source of income. So even though it might not be a huge 440 
source of income but because of the precarious state a lot of GPs are around the country even 441 
smaller reduction in their income will have a destabilising effect” [P14-GP] 442 
 443 
 444 
 445 
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Motivation 446 
Motivation enablers for delivering DPS as part of the primary care network included 447 
incentives. Community pharmacy participants also felt that, to avoid competition, future 448 
services should offer benefits for general practices as an incentive for them to endorse 449 
community pharmacy services.  450 
“It will depend on, if obviously the doctors have got QOF targets and they will be paid for a similar 451 
thing then they’re not going to be sending people to me if they can get that money isn’t it” [Quality and 452 
Outcomes Framework - a reward and incentive programme for all GP surgeries in England, detailing 453 
practice achievement results] [P5-Pharmacist] 454 
Self-efficacy, enhanced by training and experience, was also seen as fundamental for 455 
motivating community pharmacy teams to deliver DPS. Some participants felt that it was 456 
also important for other members of the primary care team, particularly GPs and nurses, to 457 
have confidence in community pharmacy’s ability to deliver the services. Participants also 458 
felt that self-efficacy would also increase patients’ confidence in community pharmacy’s 459 
ability to deliver DPS.  460 
“It’s you know trying to build the confidence of the doctors in us as well and our teams because at the end of the 461 
day if we do something like this it’s unlikely it’s going to be use that’s delivering the service it’s going to be our 462 
healthcare team so they have to build up confidence in what we’re doing” [P2-Pharmacist] 463 
The greatest barrier to motivation stemmed from pharmacists feeling overwhelmed in their 464 
current role. Participants felt that their dispensary role and the provision of largely walk-in 465 
services, could be a barrier to delivering DPS which are likely to require lengthy 466 
consultations. To this end participants felt that extra resources and improved utilisation of 467 
current skill mix, particularly technicians, would be required to deliver the services.  468 
“ If you get people come marching through your door to speak to your pharmacist, and as you were 469 
saying you’ve got your methadone addicts, and you’ve got your morning after, and you’ve got your 470 
MUR’s [Medicines Use Reviews], it sometimes as a pharmacist you don’t know where your backside 471 
is really because you're everywhere”  [P6- Pharmacist] 472 
 473 
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 474 
Discussion 475 
This study highlights the potential for community pharmacy to deliver diabetes prevention 476 
services and presents factors in terms of Capability, Opportunity and Motivation at both local 477 
and national levels that could facilitate implementation. 478 
 479 
The accessibility of community pharmacy has been identified in this study as a factor that 480 
could increase opportunity for people with pre-diabetes to engage with screening, 481 
glycosylated haemoglobin (HbA1c) monitoring and lifestyle interventions. A recent evaluation 482 
of the NHS DPP has recommended the programme be linked with other services in primary 483 
care and has highlighted the importance of increasing accessibility to targeted populations 484 
(32). Therefore, with previous research demonstrating willingness amongst people with pre-485 
diabetes to engage with DPS in community pharmacy (Katangwe T, 2019, unpublished data)  486 
and that people with pre-diabetes are more likely to be prescribed lipid lowering and anti-487 
hypertensive drugs (33), community pharmacy could potentially have sufficient information to 488 
conduct focused screening and intervention services. However, since the lack of access to 489 
full medical notes was considered a barrier of delivering DPS in community pharmacy, the 490 
extent to which full access to medical notes would be needed to deliver the DPS would need 491 
to be established.   492 
 493 
This study has also highlighted several important physical and social factors including time, 494 
resources and funding, that if addressed could enhance opportunity for community 495 
pharmacy teams to deliver DPS. This resonates with recent UK research which has 496 
demonstrated that despite the willingness of community pharmacy teams to deliver public 497 
health interventions, factors such as lack of time and funding remain major hindrances (34).  498 
The need for integration of future community pharmacy services with other primary care 499 
services has also been identified. Factors affecting current integration in primary care such 500 
21 
 
as the lack of integrated IT systems, poor relationships with general practices, competing 501 
payment structures and lack of awareness of community pharmacy roles and skills have 502 
been identified and would need to be addressed for future provision of community pharmacy 503 
services.  504 
 505 
An independent review of community pharmacy clinical services commissioned by NHS 506 
England in 2015 also identified integration of community pharmacy within primary care as 507 
crucial for the provision of future services (35). Potential solutions highlighted by both this 508 
research and the review include practical enablement such as shared clinical records and 509 
the ability to communicate with the rest of the clinical team (35).  510 
 511 
An important finding of this present study, however, is a suggestion that current community 512 
pharmacy screening interventions such as NHS Health Checks (18), which refer high risk 513 
individuals to general practice services for further testing, could potentially be increasing  514 
general practice workload. A recent report on understanding general practice pressures has 515 
highlighted the changing relationship between general practices and the wider healthcare 516 
system as a contributor to workload and has highlighted referrals and communication as 517 
time consuming factors both for medical and administrative general practice staff (36). It is 518 
important therefore that future community pharmacy services should seek to reduce 519 
pressure on general practice rather than increase it. Additionally, an evaluation of the NHS 520 
health check service has shown poor attendance amongst people referred to general 521 
practice services following screening in community pharmacy (18). The evaluation 522 
demonstrated that almost half the people referred to other lifestyle interventions following 523 
community pharmacy services were unwilling to engage. This highlights that whilst some 524 
individuals are willing to engage with community pharmacy services, not all may be willing to 525 
engage with other primary care services.  526 
 527 
22 
 
Previous research conducted in Australian community pharmacies shows that risk 528 
assessments followed by fasting plasma glucose tests resulted in fewer referrals and greater 529 
uptake by patients (37). More recent research conducted in Norwegian community 530 
pharmacies has further demonstrated the feasibility for community pharmacy to implement 531 
HbA1c screening services (14). With current guidelines for the diagnosis and referral into 532 
NHS DPP requiring HbA1c screening,(17) there is potential for community pharmacy in 533 
England to be involved in delivering comprehensive tests without requirement for referral to 534 
other primary care teams for confirmatory tests. Moreover, with research also demonstrating 535 
potential cost-effectiveness of pre-diabetes screening with appropriate intervention in 536 
community pharmacy (38), lifestyle interventions for those unwilling to engage with other 537 
primary care lifestyle interventions could be delivered in this setting.  538 
 539 
This study has highlighted training and the appropriate use of pharmacy skill mix as key 540 
factors that could enhance the capability and motivation respectively for the community 541 
pharmacy teams to deliver quality DPS. The pharmacy workforce, the third largest workforce 542 
group in the NHS, has in recent years had its potential to contribute to the delivery of public 543 
health services recognised (35). The use of pharmacy technicians, trained as lifestyle 544 
coaches, in the delivery of DPS has particularly been identified as a viable option in terms of 545 
cost and availability in the USA (15). With the NHS long term plan supporting the 546 
introduction of extended roles to ensure primary care networks can be more effective, 547 
pharmacy technicians could potentially be key players in the delivery of DPS (19). As 548 
highlighted by this study, technicians delivering DPS would need multifaceted training 549 
including theory on pre-diabetes management, consultation, coaching and behaviour change 550 
skills.  551 
 552 
 553 
 554 
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Strengths and limitations 555 
This is the first study exploring the community pharmacy setting for delivering diabetes 556 
prevention services from the perspective of multiple stakeholders. It adds to an emerging 557 
body of research applying the COM-B model to assist theory informed approaches to 558 
developing diabetes prevention interventions (39). The use of the COM-B model to identify 559 
barriers and facilitators, provides a theoretical basis for identifying suitable interventions and 560 
behaviour change techniques (through the Behaviour Change Wheel framework) that could 561 
enable the successful delivery of DPS in the community pharmacy setting. Further research 562 
is currently being undertaken to develop an intervention with strategies which will promote 563 
engagement and enable the successful delivery of DPS in the community pharmacy setting.  564 
 565 
The barriers and facilitators identified by this research could be considered when designing 566 
other, non-diabetes related, interventions in the community pharmacy setting. In England, 567 
with the role of pharmacists and pharmacy technicians expanding beyond dispensing to the 568 
clinical management and prevention of chronic conditions such as cardiovascular disease, 569 
the findings of this research could facilitate the development of interventions promoting self-570 
management in the community pharmacy setting (19, 40).   571 
 572 
A limitation of the study was the lack of participants who are directly involved in 573 
commissioning the current NHS DPP. Additionally, the use of two different data collection 574 
methods, although useful for triangulation, generated two different types of data where 575 
interviews with general practice participants and commissioners generated in depth data 576 
whilst focus groups with community pharmacy participants generated superficial data. 577 
Arguably, more ground was covered with general practice participants than community 578 
pharmacy participants, thus inadvertently, this may have caused an imbalance in the data.  579 
 580 
 581 
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Conclusions 582 
This research highlights the potential for community pharmacy to increase accessibility of 583 
both screening and lifestyle interventions in primary care. New models of services should 584 
also seek to integrate community pharmacy services in primary care to facilitate efficient 585 
communication with general practices and promote better working relationships. To enhance 586 
the capability and motivation of community pharmacy to deliver such services, multifaceted 587 
training involving coaching and behaviour change skills and the appropriate use of pharmacy 588 
skill mix is required.  589 
 590 
 591 
 592 
 593 
 594 
 595 
 596 
 597 
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Table 3: COM-B analysis of barriers and facilitators to delivering community pharmacy-based diabetes prevention 
services 
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COM-B components 
with definitions 
Mapped codes Illustrative quotes 
Barriers Facilitators 
Physical capability 
(Physical skill, strength or 
stamina) 
 
   Practical training “I think if the CCG is commissioning a service then they should be able to 
provide us with the practical training” [Pharmacist] 
 
Psychological capability 
(Knowledge or psychological 
skills, strength or stamina to 
engage in the necessary 
mental processes) 
 Inadequate training to deliver 
services  
 
 
 Knowledge of support staff 
 Consultation skills  
 Coaching and behaviour change 
skills 
“I think we need to be very mindful that when we’re training our staff it’s 
not just about how you use the equipment. We have to up-skill them on 
consultation skills as well, because if people are to be utilising us more, 
they also need to feel that they’re getting quality service”  
[Pharmacist] 
 
 Maintenance of knowledge/skills 
is important  
 
 “You need the skills to be concentrated because if like say for example in 
the past we [GP practice] used to provide smoking cessation services, but 
we felt that we were not dealing with enough number of services so that 
our skills would remain at a high level” [GP] 
 
Physical opportunity – 
(Opportunity afforded by the 
environment involving time, 
resources, locations, cues, 
physical affordance) 
 
  Accessibility 
 
“It’s about access as well. I think access is very important because I’ve 
had customers, they would have gone to the GP otherwise if we weren’t 
closer… one of them had to go in a wheelchair on the bus to go all the 
way to the surgery whereas they could just leave the house go in the 
wheelchair to the pharmacy and have it [Flu vaccination] done and then 
go home, so for them it’s easy access” [Pharmacist] 
 
  CP setting well placed to deliver 
pre-diabetes services  
 
“How easy would it be to actually do things like mass screening in 
community pharmacy and the answer is really really easy…community 
pharmacy could be picking up pre-diabetics and you know giving the 
intensive lifestyle advice, weight management etc. you know that’s such a 
piece of cake” [Commissioner] 
 
  CP screening for NHS DPP could 
deliver faster referrals than 
surgeries 
 
“ I think it could only be a good thing for everybody because the delay in 
patients getting appointments in a busy practice means that if they are 
able to go via the pharmacist then they would get the referral quicker than 
perhaps waiting for an appointment to see somebody here to then be 
referred into the system” [Nurse] 
 
  Appointment systems with shorter 
waiting times than general 
practice 
 Walk in services 
“Actually, booking appointments, I think, works for a lot of people even if 
they have to wait ten minutes. I think that’s better than what they have to 
wait at the doctors surgery’s” [Pharmacy technician] 
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  A time-flexible alternative  “I think it’s again going back to individualisation…some patients would 
chose not to engage in the prevention programme, they may feel I don’t 
want to go to my GP surgery, I can’t ever get an appointment or I don’t 
have time to go there because their lifestyle and choices and things. So if 
they are willing to engage with their local pharmacy I would say its surely 
better that they engage with somebody and receive that advice and 
education that they need than getting signposted to somewhere that they 
are not going to follow-up with and not get any education at all”  
[Nurse] 
 
 Time pressure barrier to 
delivering diabetes prevention 
services 
 Pharmacist time constraints 
hindering delivery of services 
 
 “I can see this eruption this volcano erupting and suddenly not only will 
general practice be overwhelmed but so will the pharmacist delivering 
one to one because its very time consuming” [Nurse] 
 
 
 Time pressures leading to low 
quality service delivery 
 Delivery of public health services 
need adequate time 
 
“With diabetes our main problem is that we don’t have time of such for 
these kind of things we do them of course but there are a lot of time 
restraints that limit of us to the sort of quality that we may be able to give 
our patients with the services” [Pre-registration pharmacist] 
 
 Space challenges 
 
 “In terms of other barriers some pharmacies it would be their consultation 
rooms aren’t necessarily ideal” [Commissioner] 
 
 Lack of access to medical 
records 
 “ The only thing I would say is that I don’t see how a pharmacy can help 
with medication reviews and tell patients they shouldn’t be taking certain 
drugs when they don’t have access to their blood results for some cases 
[laughter]” [Nurse] 
 
 Funding cuts a barrier to CP 
delivering more services 
 
 Future CP services would need to 
be well funded 
 
“You know what 6% shaved off! I mean that 6 seems like a small number 
but that’s big money you know because it’s paying for your staff to be 
able to deliver these services so that’s what it comes down to…we’re in 
this difficult situation right now… we want to be doing more we want to be 
involved more and like we’re tied, really we’re tied to the dispensary, 
we’re tied to these prescriptions” [Pharmacist] 
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 Lack of resources to deliver 
beneficial services 
 “To give those services out and be beneficial to the patients a second 
pharmacist is always good...I mean we’ve got a second pharmacist in in 
our pharmacy for at least 4 days a week haven’t we but they said you 
know they are trying to that is getting harder and harder to fund”  
[Pharmacy technician] 
 
 Current CP services not 
Integrated in primary care 
 Pharmacists cannot deliver DPS 
without general practice  
 Perceives CP diabetes 
prevention services as 
fragmentation of primary care 
services  
 
 Integration in primary care 
 Commissioning model and 
integration fundamental 
 CP and GP need to work together 
more 
 General practice should refer 
patients into new CP services 
 
“The issue with all community pharmacy services at the moment is that 
they are not integrated at the end of the day they are an afterthought a 
bolt on…work separately” [Commissioner] 
 Current follow-up systems not 
efficient  
 Lack of feedback from CP 
services hindering referrals 
 Poor feedback from GP practice 
following CP referrals 
 IT systems not merged with GPs 
hindering GP referrals, follow-up 
and leading to duplication of 
work  
 
 Effective communication, 
feedback and referral systems to 
general practice are needed for 
the delivery of services 
IT connectivity fundamental for 
CP-GP integrated services 
“You need the IT solutions etc. to be able to pass that information back to 
the GP practice, because at the moment it’s not an integrated system. So 
IT connectivity and read write abilities etc. are kind of fundamental I think 
to the integration of community pharmacy service going forward”  
[Commissioner] 
 
Social opportunity 
(Opportunity afforded by 
interpersonal influences, 
social cues and cultural 
norms that influence the way 
that we think about things 
e.g. the words and concepts 
that make up our language)  
 
 
 Challenges in funding services 
traditionally provided by general 
practice  
 No dedicated budget pot for 
commissioning CP services 
 “One of the problems at the moment with the way that commissioning 
happens in the NHS in primary care is if we are commissioned to do 
something that is a job that traditionally might have been done by the GP 
practice, how do you release that money?. You are not going to de-
commission the GP practices, you’re not going to take money away from 
them etc. so how do you then fund that work that is being transferred to 
community pharmacy?” [Commissioner]  
 
 Commissioners do not prioritise 
CP 
 Pharmacy underrepresented in 
CCGs 
 Commissioners envision 
primary care as primary 
medical care (which doesn't 
 “I think the biggest barrier to developing community pharmacy services is 
the fact that commissioners at a local level do not see it as priority”  
[Commissioner] 
 
32 
 
include CP) 
 
  Increased awareness 
 Targeted awareness  
 CP services awareness - 
responsibility of all HCP including 
CP 
 
“I think the diabetes prevention program would be another good service 
we provide though provided we create the awareness so that people 
would know we are doing that, we’ve got the training to do that”  
[Pharmacist] 
 Patient barriers - only wanting to 
engage with prescription 
services 
 Need positive promotion of CP i.e. 
not as cheaper alternative but 
accessing right level of care 
 Patient need to move in with the 
times and start using other HCP 
more rather than expecting to see 
GP 
 
“I think also the raising of awareness of pharmacy need to be in a positive 
way, because you know the stuff that I’ve seen around pharmacy has 
been you know doctors too busy so go and see your pharmacist, or 
medicines are costing too much money go buy them cheaper in the 
pharmacy, and so I’m not 100% sure that that message is wholly positive” 
[Pharmacist] 
 
 Ethical challenges with 
promoting CP services 
 
 “Then again there’s another point with private companies like [pharmacy 
multiples] trying to advertise for services. It’s like this is a health thing do I 
really advertise it like I’m advertising for maybe perfume or milk? There’s 
that ethical aspect” [Pharmacist] 
 Lack of awareness of CP 
services (GP) 
 GP only aware of pharmacist 
role in medication 
 Lack of knowledge of CP role 
and skills  
 
 “I think that GP’s don’t understand, have no idea what pharmacists know 
and what pharmacists could do in community pharmacy… it’s just a lack 
of knowledge about that” [GP practice pharmacist] 
 Sceptical if prevention service is 
feasible in CP setting 
Sceptical if CP is the best setting 
for delivery of diabetes 
prevention advice 
 
 “I mean if they’ve got the appropriate resources then I can’t see any major 
disadvantages, but whether it’s feasible to provide all these services in a 
pharmacy setting I am not so sure, and whether one person can do all 
these things am not so sure” [GP] 
 Sceptical about follow-up 
following screening in CP 
 CP public health screening 
services with no follow-on 
programmes wasting primary 
care resources 
 “In terms of screening I can’t see any reason why it can’t be done outside 
of the surgery setting but I am a bit sceptical about how that would be 
dealt with in by the pharmacist. Meaning is it going to be a case of them 
just doing a blood test and then if they’ve got an HbA1c of 42 say oh go 
and see your GP or whether they can then give any focused advice about 
that or whether they would be empowered to do the necessary referrals to 
the say for example the diabetes prevention programme” [GP] 
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 Commissioning CP services 
difficult due to multiple 
contractors 
 
 Commissioning for outcomes 
better model of demonstrating 
impact of service 
 
“They need to know what we they are commissioning and commissioning 
for outcomes… unless you can say what you are going to deliver and 
performance manage it then you know it’s always going to be 
questionable as to the impact that you’re providing” [Commissioner] 
 
 Commissioning CP services 
difficult due to multiple 
contractors 
 
 “Obviously we’ve got yes some big providers like [name of pharmacy 
multiples]… but we’ve also got individuals and if you were an evolving 
care organisation…an accountable care organisation and you wanted to 
commission something like that from community pharmacy….how do you 
manage it…in an area might be 30, 40, 50, 60 different contractors… so 
you need a vehicle really to actually deliver that” [Commissioner] 
 
 Competing interest in delivering 
services 
Competing interest with GP 
practices for services 
 “With regards to services moving out of primary care, if GPs provide the 
screening services then we get...as I said to you earlier we get kind of 
paid for it and it’s a source of income. So even though it might not be a 
huge source of income but because of the precarious state a lot of GP 
are around the country even smaller reduction in their income will have a 
destabilising effect” [GP] 
 
 Competing interest affecting CP-
GP relationships  
 “There is some competition between services especially the flu 
vaccination…  there’s been quite a lot of inappropriate advertising from 
both sides in the past few years to try to get patients so that’s something 
that kind of ruins the relationship a little bit”  
[Pharmacy technician] 
 
 GP perceiving that CP has an 
ulterior motive for providing 
services 
 Perceives CP delivering pre-
diabetes advice as stepping on 
GPs toes 
 
 DPP would need to be positively 
promoted to practices to ensure 
they don't see it as challenge 
upon their services 
“Our satisfaction rates are have always been high in spite of whatever the 
newspaper say… and that's because we feel that the patients feel that we 
are doing what we are doing for them rather than for any other ulterior 
motive. I guess when they going to see a pharmacist even if they are very 
altruistic, even if they want to be just doing good for the patients, there 
always the suspicion if is it really just for me or is it because they are after 
their bottom line yeah so I don’t know” [GP] 
  Pre-diabetes education not 
efficient use of GP time 
 
“We were referring patients to the health trainer…anyone who was 
diagnosed with [pre-] diabetes was sent her way because it’s not actually 
it’s not efficient use of our time to really educate somebody with pre-
diabetes” [GP] 
 
 GP practices not referring 
patients to CP public health 
services  
 “There is an awful lot of surgeries that can't engage because they are 
busy as well and can't and don’t want to engage but they are not 
necessarily referring patients to community pharmacy”  
[Commissioner] 
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 Potential patient resistance 
because historically they would 
see a nurse or a GP for diabetes 
services  
 
 GP endorsement of CP services 
would positively influence uptake 
 GP endorsement of CP DPP 
would be important for instilling 
confidence in patients 
 
“If the GP’s were to promote pharmacy then I think a lot more people will 
be more willing to uptake services” [Pharmacist] 
  CP could help reduce GP 
workload  
 
“I think that’s good because from our point of view as primary care and 
GP practice were trying to reduce our footfall as much as possible in 
terms of patients coming into the surgery for things that can be dealt with 
by pharmacies” [Nurse] 
 
 CP time pressure leading to 
unwarranted referrals to general 
practice 
 CP public health screening 
services creating more referrals 
and workload for general 
practice 
 
 “ If they are doing those things we need to see it…referring back if we 
need to something the only problem with that is that its more workload for 
us but it’s only the same as someone getting a private medical and then 
we have to deal with that so” [GP]  
 Fear of overwhelming working 
environment that CP DPS could 
create in primary care  
 “I can see this eruption this volcano erupting and suddenly not only will 
general practice be overwhelmed, but so will the pharmacist delivering 
one to one” [Nurse] 
 Poor relationships with 
pharmacy multiples 
 
 Positive working relationships with 
general practice-owned 
pharmacies 
 Good referral systems depending 
on relationships 
 
“I suppose because we have got our own pharmacy we just work through 
…yes so we know them all so they are employed by the practice so we’ve 
got pharmacy patients and dispensary patients so it’s all done within the 
practice” [GP] 
  GPs need to have confidence in 
pharmacy team ability to deliver 
DPP 
 
“It’s you know trying to build the confidence of the doctors in us as well 
and our teams because at the end of the day if we do something like this 
it’s unlikely it’s going to be use that’s delivering the service it’s going to be 
our healthcare team so they have to build up confidence in what we’re 
doing” [Pharmacist] 
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CP need to build trust with GPs “Yeah I mean I guess there ought to be a bit more kind of trust in 
between, I think it’s mostly a trust issue. If GPs are to trust that what they 
are doing they are doing it properly and then the GPs don’t have to take 
up the extra burden but not be paid for it, then I think it would work well” 
[GP] 
 
 Potential resistance from 
general practice because 
historically patients go to a GP 
setting for diabetes services 
 
 “I would imagine that there could potentially be some resistance from 
obviously places like us as a GP setting, because historically it would 
always be that you came to your GP and you know if the GP or the 
practice nurse or whoever would see you and diagnose you and give you 
advice and so on” [Nurse] 
 
 GPs perceiving to be better than 
pharmacists at giving pre-
diabetes due to extensive 
knowledge of diabetes and 
associated co-morbidities  
 
 GPs perceiving to be better 
placed to give pre-diabetes 
opportunistic advice due to links 
with co-morbidities in patients 
the consult  
 
 “I think the background knowledge is very important but what is also 
important is the experience behind it. I mean it will be very difficult for a 
pharmacist to replicate the experience which a GP will have because 
diabetes is not just diabetes, its kidney disease, its heart disease, its 
peripheral vascular disease and we see it day in and day out. I think a 
pharmacist will be adjunct to this but I don't think pharmacists will be able 
to do this all on their own.” [GP] 
 
 
Reflective motivation 
(Reflective processes 
involving plans (self-
conscious intentions) and 
evaluations (beliefs about 
what is good and bad)) 
 
 
 
 
  Use pharmacy skill mix to deliver 
diabetes prevention services 
 CP public health interventions 
don’t have to delivered by 
pharmacists 
 
“We are supposed to be utilising and making best use of the skills mix … 
because as much as we get frustrated with the monotony of our role as 
do our dispensers and our healthcare assistants so introducing these 
things can make them feel challenged and provide opportunities for 
growth” [Pharmacist] 
 
 Dispensary role of pharmacist 
hindering scope to deliver more 
services 
 Pharmacy workload hindering 
delivery of services 
 
 Appropriate allocation of 
resources 
 
“Our employers have to be on-board properly. We need the support 
unless this can be done by a designated member of staff, but if it’s on the 
pharmacists again then that would be a problem because as it is there is 
so much that I need to do” 
 [Pharmacist] 
 
 Inadequate training leading to 
lack of confidence 
 Self-efficacy of staff in delivering 
services enhanced by training and 
experience 
 
“I think it’s imperative that you know the services are standardised across 
the board that will instil confidence ok for us and also for the patients you 
know you don’t want your patient to come in and you don’t know what 
you’re doing” [Pharmacist] 
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 Confidence of patient and GPs on 
CP delivering services enhanced 
by training and experience 
 
 Lack of structure to deliver 
particular services leading to 
pressure on pharmacist 
resources 
 
 Overwhelming experience 
created by unstructured delivery 
of CP services 
 
 
 
 
 
 
 
 
“ If you get people come marching through your door to speak to your 
pharmacist, and as you were saying you’ve got your methadone addicts, 
and you’ve got your morning after, and you’ve got your MUR’s, it 
sometimes as a pharmacist you don’t know where your backside is really 
because you're everywhere”  [Pharmacist] 
 
 Implementation of service with GP 
to alleviate tensions caused by 
competing interests  
“The worry is if the GP’s think oh you’re just taking their job away…so it’s 
trying to make sure that we get a good conversation going with the GP’s 
and actually come up with a good way to actually implement the service 
with them” [Pharmacist] 
 
  Delivering pre-diabetes lifestyle 
advice does not require one to 
have a medical degree 
 
“As a GP I mean I do do an awful lot of it [lifestyle advice] 
opportunistically within the consultation because it relates to so many 
things… blood pressure and anything but you don’t need a medical 
degree to give lifestyle advice” [GP] 
 
Automatic motivation 
(Automatic processes 
involving emotional 
reactions, desired (wants 
and needs), impulses, 
inhibitions, drive states and 
reflex responses) 
 GPs will only endorse services if 
there something in it for them 
 “If obviously the doctors have got QOF targets and they will be paid for a 
similar thing then they’re not going to be sending people to me if they can 
get that money isn’t it” [Pharmacist] 
 
  CP diabetes prevention services 
would bring in financial benefits 
 
“So cost wise in providing the service I think it would be cheaper for the 
NHS  for us to do it [deliver DPS] than to get the GP surgery’s to do 
that…also hopefully they will channel a little bit of money you know from 
there into the community pharmacy so that they can provide us with extra 
hands that we need” [Pharmacist] 
 
 Pharmacists intimidated by GPs 
- affecting relationships 
 
 “I think as pharmacists we can find it you know really difficult to talk to 
GP’s sometimes… I think of what I used to be like with consultants, they 
seemed you know they were up here…that’s a personality thing 
sometimes and I think it would be the same” [GP practice pharmacist] 
 
